SCHEMBL24258665

SCHEMBL24258665

Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OC[C@@H]2[C@@H](CO[P@@](=O)(O)S)C[C@H]2n2cnc3c(=O)n4cnnc4[nH]c32)C[C@H]1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FHIT P49789 5/20 0.39
▸ BCHE P06276 2/20 0.37
▸ NT5E P21589 1/20 0.37
▸ P2RY1 P47900 4/20 0.37
▸ P2RY2 P41231 3/20 0.37
▸ SRC P12931 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ DNPH1 O43598 1/20 0.37
▸ PRKAB2 O43741 1/20 0.37
▸ TRPM2 O94759 1/20 0.37
▸ LDHA P00338 1/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ FBP1 P09467 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ PRKAG1 P54619 1/20 0.37
▸ PRKAA2 P54646 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ PRKAA1 Q13131 1/20 0.37
▸ PDE3A Q14432 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258666 0.90 POLB (0.37) FHITBCHEP2RY1RNASEL
SCHEMBL24258642 0.82 BCHE (0.35) FHITBCHEP2RY1RNASEL
SCHEMBL24258634 0.82 BCHE (0.35) FHITBCHEP2RY1RNASEL
SCHEMBL24258604 0.81 POLB (0.41) FHITP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL24258605 0.81 POLB (0.36) FHITBCHEP2RY1
SCHEMBL24258656 0.80 TAS1R3 (0.42) FHITBCHENT5EP2RY1P2RY2
SCHEMBL24258668 0.80 TAS1R3 (0.42) FHITBCHENT5EP2RY1P2RY2
SCHEMBL24258615 0.80 RNASEL (0.38) FHITBCHEP2RY1P2RY2SRC
SCHEMBL21540024 0.79 P2RY1 (0.56) BCHENT5EP2RY1P2RY2SRC
SCHEMBL22524006 0.79 P2RY1 (0.56) BCHENT5EP2RY1P2RY2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752516-B1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL MYERS SQUIBB CO (US) 2022-02-23 — — EP disclosed
Send feedback